Japan: Food and Drugs Law

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Key Regulatory Considerations For Pharmaceuticals And Medical Devices In Japan

Japan's healthcare market is undergoing a significant transformation driven by an aging population and technological innovation.

Japan Healthcare

Oh-Ebashi LPC & Partners

Publication Of The "Casebook On Antimonopoly Law For Industrial Structural Reform To Ensure Stable Supply Of Generic Drugs"

On February 17, 2025, the Ministry of Health, Labour and Welfare ("MHLW") and the Japan Fair Trade Commission ("JFTC") published the Casebook on Antimonopoly Law for Industrial Structural Reform...

Japan Healthcare

AM

Anderson Mori & Tomotsune

「後発医薬品の安定供給等の実現に向けた産業構造改革のための独占禁止法関係事例集」の公表

厚生労働省及び公正取引委員会（以下「公取委」という。）は、2025 年 2 月 17 日、「後発医薬品の安定供給等の実現に向けた産業構造改革のため

Japan Healthcare

AM

Anderson Mori & Tomotsune

Innovative 3D Printing In Healthcare: From Design To Drug Delivery

The latest advancements in Additive Manufacturing (AM) or 3D printing technology represent a remarkable breakthrough in the pharmaceutical sector. From diagnostics to drug delivery, 3D printing is empowering.

Japan Healthcare

MC

Marks & Clerk

Life Science Newsletter February 2025 (Japanese)

Japan Healthcare

AM

Anderson Mori & Tomotsune

Life Science Newsletter February 2025

Japan Healthcare

AM

Anderson Mori & Tomotsune

Life Science Newsletter (January 2025)

Japan Healthcare

AM

Anderson Mori & Tomotsune

No Drug? No Dice! Clarifying Orange Book Eligibility For Drug-Device Patents

Japan Healthcare

YMF Law Tokyo

Japan's MHLW Highlights Four Key Themes In Pharmaceuticals And Medical Devices Act Timeline Amendment

Japan Healthcare

RG

Ropes & Gray LLP

Request For Public Comments On The Revised Draft "Guidelines For Distribution Stakeholders To Adhere To For Improving The Distribution Of Medical Pharmaceuticals"

Japan Healthcare

AM

Anderson Mori & Tomotsune

Updates On Drug Regulations In Japan – Reducing Barriers To Entry For Drug Companies Entering The Japanese Market

Japan Healthcare

WS

Winston & Strawn LLP

Overview Of Medical Advertising Regulations

Japan Healthcare

AM

Anderson Mori & Tomotsune

US FTC Agrees Consent Order With DNA Testing Companies On Privacy Breaches Over Data On Genetic And Health Information, Including 20 Years Of Improved Management

Japan Healthcare

AM

Anderson Mori & Tomotsune

Digital Healthcare 2023

Japan Healthcare

AM

Anderson Mori & Tomotsune

RWA (Real World Asset) Token And Relating Legal Issues Under Japanese Law

Japan Technology

AM

Anderson Mori & Tomotsune

Environmental, Social & Governance Law Japan 2025

Japan Commercial

AM

Anderson Mori & Tomotsune

Japan Technology

AM

Anderson Mori & Tomotsune

Blockchain Comparative Guide

Japan Technology

Chuo Sogo LPC

Innovative 3D Printing In Healthcare: From Design To Drug Delivery

Japan Healthcare

MC

Marks & Clerk

Food and Drugs Law

Key Regulatory Considerations For Pharmaceuticals And Medical Devices In Japan

Japan's healthcare market is undergoing a significant transformation driven by an aging population and technological innovation.

Japan Healthcare

Oh-Ebashi LPC & Partners

Publication Of The "Casebook On Antimonopoly Law For Industrial Structural Reform To Ensure Stable Supply Of Generic Drugs"

On February 17, 2025, the Ministry of Health, Labour and Welfare ("MHLW") and the Japan Fair Trade Commission ("JFTC") published the Casebook on Antimonopoly Law for Industrial Structural Reform...

Japan Healthcare

AM

Anderson Mori & Tomotsune

「後発医薬品の安定供給等の実現に向けた産業構造改革のための独占禁止法関係事例集」の公表

厚生労働省及び公正取引委員会（以下「公取委」という。）は、2025 年 2 月 17 日、「後発医薬品の安定供給等の実現に向けた産業構造改革のため

Japan Healthcare

AM

Anderson Mori & Tomotsune

Innovative 3D Printing In Healthcare: From Design To Drug Delivery

Japan Healthcare

MC

Marks & Clerk

Life Science Newsletter (January 2025)

Japan Healthcare

AM

Anderson Mori & Tomotsune

No Drug? No Dice! Clarifying Orange Book Eligibility For Drug-Device Patents

Japan Healthcare

YMF Law Tokyo

Japan's MHLW Highlights Four Key Themes In Pharmaceuticals And Medical Devices Act Timeline Amendment

Japan Healthcare

RG

Ropes & Gray LLP

When It Should Be Obvious That "You Don't Know What You Don't Know"—Salix V. Norwich

YMF Law Tokyo

IP News Bulletin For Japan & China (March2024)

SK

Sonoda & Kobayashi Intellectual Property Law

See more

Life Sciences, Biotechnology & Nanotechnology

Key Regulatory Considerations For Pharmaceuticals And Medical Devices In Japan

Japan's healthcare market is undergoing a significant transformation driven by an aging population and technological innovation.

Japan Healthcare

Oh-Ebashi LPC & Partners

「後発医薬品の安定供給等の実現に向けた産業構造改革のための独占禁止法関係事例集」の公表

厚生労働省及び公正取引委員会（以下「公取委」という。）は、2025 年 2 月 17 日、「後発医薬品の安定供給等の実現に向けた産業構造改革のため

Japan Healthcare

AM

Anderson Mori & Tomotsune

Life Science Newsletter February 2025 (Japanese)

2025 年 2 月 13 日、公正取引委員会が医療機器等の製造販売業者の確約計画を認定しました。

Japan Healthcare

AM

Anderson Mori & Tomotsune

Life Science Newsletter February 2025

Japan Healthcare

AM

Anderson Mori & Tomotsune

Life Science Newsletter (January 2025)

Japan Healthcare

AM

Anderson Mori & Tomotsune

No Drug? No Dice! Clarifying Orange Book Eligibility For Drug-Device Patents

Japan Healthcare

YMF Law Tokyo

Japan's MHLW Highlights Four Key Themes In Pharmaceuticals And Medical Devices Act Timeline Amendment

Japan Healthcare

RG

Ropes & Gray LLP

In Vivo Production And Patent Infringement—An Issue Of First Impression In Japan's IP High Court

YMF Law Tokyo

Request For Public Comments On The Revised Draft "Guidelines For Distribution Stakeholders To Adhere To For Improving The Distribution Of Medical Pharmaceuticals"

Japan Healthcare

AM

Anderson Mori & Tomotsune

See more

Healthcare

Key Regulatory Considerations For Pharmaceuticals And Medical Devices In Japan

Japan's healthcare market is undergoing a significant transformation driven by an aging population and technological innovation.

Japan Healthcare

Oh-Ebashi LPC & Partners

Publication Of The "Casebook On Antimonopoly Law For Industrial Structural Reform To Ensure Stable Supply Of Generic Drugs"

On February 17, 2025, the Ministry of Health, Labour and Welfare ("MHLW") and the Japan Fair Trade Commission ("JFTC") published the Casebook on Antimonopoly Law for Industrial Structural Reform...

Japan Healthcare

AM

Anderson Mori & Tomotsune

「後発医薬品の安定供給等の実現に向けた産業構造改革のための独占禁止法関係事例集」の公表

厚生労働省及び公正取引委員会（以下「公取委」という。）は、2025 年 2 月 17 日、「後発医薬品の安定供給等の実現に向けた産業構造改革のため

Japan Healthcare

AM

Anderson Mori & Tomotsune

Innovative 3D Printing In Healthcare: From Design To Drug Delivery

Japan Healthcare

MC

Marks & Clerk

Life Science Newsletter (January 2025)

Japan Healthcare

AM

Anderson Mori & Tomotsune

No Drug? No Dice! Clarifying Orange Book Eligibility For Drug-Device Patents

Japan Healthcare

YMF Law Tokyo

Japan's MHLW Highlights Four Key Themes In Pharmaceuticals And Medical Devices Act Timeline Amendment

Japan Healthcare

RG

Ropes & Gray LLP

Lost In Interpretation: How Claim Construction Doomed AlexSam's Case Against Cigna

YMF Law Tokyo

Updates On Drug Regulations In Japan – Reducing Barriers To Entry For Drug Companies Entering The Japanese Market

Japan Healthcare

WS

Winston & Strawn LLP

See more

Latest Videos

See more

Sidharrth Shankar | Indian Healthcare Sector In 2023 And Way Forward In 2024 (Video)

J

JSA

How To Export Cosmetics To Thailand (Video)

TG

Tilleke & Gibbins

Indian Healthcare Today - New Opportunities And Access To Growth (Video)

NP

Nexdigm Private Limited

RHTLaw Taylor Wessing Healthcare Life Sciences Industry Group (Video)

RT

RHTLaw Taylor Wessing

The Indian Medical Device Industry 23 October 2017 (Video)

ND

Nishith Desai Associates

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More